United Maritime Capital’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,700
Closed -$1.33M 33
2022
Q1
$1.33M Hold
7,700
3.63% 8
2021
Q4
$1.96M Buy
7,700
+2,750
+56% +$804K 2.25% 11
2021
Q3
$1.91M Buy
+4,950
New +$1.83M 2.12% 13

Other funds holding MRNA

United Maritime Capital's MRNA Position: Q2 2022 in Review

United Maritime Capital sold out of Moderna (MRNA) in Q2 2022, closing a stake of 7,700 shares — an estimated $1.33M sold.

United Maritime Capital first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $1.96M in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • United Maritime Capital reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • United Maritime Capital sold 7,700 Moderna shares in Q2 2022, an estimated $1.33M.
  • United Maritime Capital first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • United Maritime Capital's Moderna position peaked at $1.96M in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on United Maritime Capital's 13F filing for Q2 2022, filed 12 Aug 2022.